Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Latest Drug Shortage - Phenylephrine

Wednesday, May 04, 2011

American Regent, one of the largest manufacturers of injectable medications is suspending all production of Phenylephrine HCI injection of 10mL, 5mL, and 1mL vials and has no estimate of a release date at this time.

On April 25, 2011, FDA reported that two drug manufacturers  of Phenylephrine (Baxter and Sandoz) are also experiencing a delay in production of the drug as a result of the recent change in market requirements.

Due to American Regent’s suspension of Phenylephrine production, Baxter manufacturer is experiencing a backorder delay on 1 mL and 10mL vials of Phenylephrine HCI injection drug. However, Baxter has accelerated production and anticipates having Phenylephrine available in mid May. Additional lots are scheduled for manufacturing and are anticipated to be available for distribution in the June – July timeframe.

Sandoz is also experiencing a backorder of 10 mL and 5 mL vials of Phenylephrine HCI injection as the current market demand is more than the company’s current inventory can meet. Sandoz anticipates increased product availability by the end of May.

ASA has been informed that Luitpold Pharmaceuticals, the parent company of American Regent Manufacturer, is in the process of developing a plan, in conjunction with the FDA that will allow it to resume manufacturing and distribution of its American Regent Drug products as soon as possible.

 

« Back to Washington Alerts